TMC Unilabs Academy develops innovative biomarker medical education specifically designed for oncologists, helping them enhance their knowledge and clinical skills. Our programs use case simulations to help enhance skills needed for biomarker driven decision making. The latest module, Oncogene-driven lung cancer has been developed by leading experts in the field. Register now to elevate your expertise in Lung Cancer! To register click here: https://lnkd.in/dm4FMGE7 #Oncology #Bayer #NSCLC
TMC’s Post
More Relevant Posts
-
⬇ Lower GI cancer update from ASCO! ⬇ GI CONNECT experts share their views on new rectal and colorectal cancer data presented at ASCO 2024. #medicaleducation #oncology #ASCO24
🚨Lower GI cancer highlights from #ASCO24🚨 Medical oncologists Prof. Jenny Seligmann and Dr Dominik Modest share their views on new data in rectal cancer and colorectal cancer from the NEOPRISM-CRC trial & LBA3512 presented at ASCO 2024. Watch the video below 📺 👇 #MedicalEducation #oncology Supported by an Independent Medical Education Grant from Bayer.
-
#NEWS Today, we announced the advancement of three studies in our clinical trial program — two studies in patients with non-muscle invasive bladder cancer (NMIBC), and one study in patients with upper tract urothelial cancer (UTUC). Read more here: https://bit.ly/4geibMN. This post is intended for healthcare professionals in the U.S. only. #UroOncology
-
-
Precision Medicine I Pharma/Biotech I Global Strategic Partnering I Biomarker Discovery I Drug Development I Clinical Trials I Oncology Therapeutics I Cell & Gene Therapy I Companion Diagnostics Commercialization
Breakthroughs in liquid biopsies and machine learning are transforming cancer care. The latest episode of Labcorp Perspectives: Oncology brings expert insights from ASCO on how these innovations are advancing diagnosis, guiding targeted therapy and improving patient outcomes. Discover how Labcorp supports diagnostic advancements through rigorous research and development. Watch now: https://lnkd.in/eStSyjfZ #Oncology #LiquidBiopsy #PrecisionMedicine #CancerResearch #CancerDiagnostics
-
⏳🇺🇸 3 days until #ASCO2024! 🚀 Next Friday, the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago will start. On June 1, between 9:00 and 12:00, XENOTHERA will present the first data from the XON7 FIPO trial, abstract 2673. Professor Jaafar Bennouna from Hopital Foch (Suresnes, France) and Dr. Françoise Shneiker, Medical Director at XENOTHERA, will share the initial clinical data on XON7, our innovative glyco-humanized polyclonal antibody showing promise for patients with refractory solid tumors. We look forward to discussing our innovative research and its potential impact on cancer treatment. #XON7 #ClinicalTrial #Solidtumors #Oncology #Innovation #PatientCare #CancerResearch
-
-
Mainz Biomed Launches Advanced ColoAlert for Better Screening https://lnkd.in/g6SYHdAi Introducing the groundbreaking Advanced ColoAlert by Mainz Biomed, a state-of-the-art colorectal cancer screening solution designed to revolutionize early detection and improve patient outcomes. This cutting-edge innovation promises to set a new standard in healthcare and enhance the effectiveness of screening processes. #mainzbiomed #colorectalcancer #healthcareinnovation #earlydetection The Leaders Magazine
-
-
Dive into the forefront of cancer research with our on-demand webinar for liquid biopsies. Explore the latest in cDNA applications and clinical biomarker identification, providing a deeper understanding of their roles in precision medicine. This webinar is your gateway to cutting-edge insights and methodologies that are shaping the future of oncology research. Watch or download at your convenience and take your research to the next level! ➡️ https://bit.ly/49Gk95c #CancerResearch #cDNA #ClinicalBiomarkers #Oncology #LiquidBiopsy
-
Breakthroughs in liquid biopsies and machine learning are transforming cancer care. The latest episode of Labcorp Perspectives: Oncology brings expert insights from ASCO on how these innovations are advancing diagnosis, guiding targeted therapy and improving patient outcomes. Discover how Labcorp supports diagnostic advancements through rigorous research and development. Watch now: https://lnkd.in/gP-cZPGz #Oncology #LiquidBiopsy #PrecisionMedicine #CancerResearch #CancerDiagnostics
-
Breakthroughs in liquid biopsies and machine learning are transforming cancer care. The latest episode of Labcorp Perspectives: Oncology brings expert insights from ASCO on how these innovations are advancing diagnosis, guiding targeted therapy and improving patient outcomes. Discover how Labcorp supports diagnostic advancements through rigorous research and development. Watch now: https://lnkd.in/epGAsEUn #Oncology #LiquidBiopsy #PrecisionMedicine #CancerResearch #CancerDiagnostics
-
Latin America Conference on Lung Cancer will start tomorrow. Discover advancements in #lungcancer therapies, encompassing ongoing clinical trials and comprehensive insights into preclinical and early clinical breakthroughs. Gain invaluable perspectives on addressing critical disparities in the region, arming yourself with actionable insights to drive change and enhance patient outcomes. If you would like to find information on similar events in one place, visit our Calendar of medical conferences, where you can filter events by date, location and cancer indications: https://lnkd.in/dnnmN4hD #oncology #medicalconference
-
-
Precision Oncogenomics - An Open Acess Journal - Elie G. Dib, MD, MS, FACP Elie G. Dib, Associate Director of the Haematology-Oncology Training Program at Saint Joseph Mercy Hospital, announced the publication of Precision Oncogenomics, a fully open-access, international, peer-reviewed journal. The journal focuses on all facets of cancer genomics research and its application in precision oncology. https://lnkd.in/eyMcns56 #OncoDaily #Oncology #Cancer #Health #Medicine #CancerResearch
-
